Study of Ataluren in Previously Treated Participants With Nonsense Mutation Dystrophinopathy (nmDBMD)

Clinical trial NCT01247207 · COMPLETED

Trial details

NCT number: NCT01247207
Sponsor: PTC Therapeutics
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Duchenne Muscular Dystrophy

Start date: 2010-11-30
Primary completion: 2026-02-10
Enrollment: 270

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.